Associate Director, Clinical Data Strategy and Operations, Oncology
Posted on: 3 Oct 2022
Lake County, IL
Job Description
The Associate Director, Clinical Data Strategy and Operations, is a leader accountable for ensuring optimized data operations and delivery of high-quality data for AbbVie’s entire clinical trial portfolio. To this end, the Associate Director drives therapeutic- and program-level strategy and coordination of data operations technology, and processes to fulfill execution expectations. The Associate Director is a highly empowered leader, a decision-maker, and influencer – cross-functionally - across the assigned TAs/programs.
Assists in the creation of TA/program strategy while also executing tactically. Supports interoperability across all internal CDSO functions and with cross-functional stakeholders.
Works to break down barriers and provides an integrated, holistic view to stakeholders.
Links needs to strategy
Facilitates the creation and convergence of technologies used for clinical trial planning and oversight.
Builds high-performing teams who focus on speed, quality, and agility as measurements of value
Forms value-add, collaborative relationships with service providers
Sponsors continuous improvement
Coaches as a core competency
Qualifications - External
Bachelor’s degree or comparable experience. Preferred degrees include health, life science, mathematics, management information systems, business, or data analytics. Master’s degree is preferred.
Proven skill in therapeutic area and program strategy development and in converting strategy to execution of data collection and management
Ability to influence without direct authority
Considerable experience with obtaining and maintaining key support in a matrix environment
Exemplary communication and presentation skills
Record of successful direct people leadership or significant leadership in matrix environment
AbbVie
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
-
IndustryBiopharmaceuticals
-
No. of Employees30, 000
-
Website
-
Jobs Posted3263
